Catalyst Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
09/05/2024 18:39
* Catalyst Pharmaceuticals Inc CPRX.OQ reported quarterly
adjusted earnings of 19 cents per share for the quarter ended
in March, lower than the same quarter last year, when the
company reported EPS of 26 cents. The mean expectation of
seven analysts for the quarter was for earnings of 17 cents per
share. Wall Street expected results to range from 14 cents to 19
cents per share.
* Revenue rose 15.4% to $98.51 million from a year ago;
analysts
expected $98.13 million.
* Catalyst Pharmaceuticals Inc's reported EPS for the
quarter was
19 cents.
* The company reported quarterly net income of $23.28
million.
* Catalyst Pharmaceuticals Inc shares had fallen by 7.7%
this
quarter and lost 12.4% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 32.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"
Wall Street's median 12-month price target for Catalyst
Pharmaceuticals Inc is $26.00
This summary was machine generated from LSEG data May 9 at 05:38
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.17 0.19 Beat
Dec. 31 2023 0.27 0.31 Beat
Sep. 30 2023 -0.28 -0.29 Missed
Jun. 30 2023 0.36 0.53 Beat